Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (524)

« Back to Publications

Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia.

Rai A. et al, (2026), The Journal of infectious diseases

Comparison of CD4 T-Cell Response in Plasmodium falciparum and vivax Malaria

Nalubega M. et al, (2026), The Journal of Infectious Diseases, 233, e891 - e901

Short‐Course Low‐Dose Primaquine for Radical Cure in G6PD ‐Normal Patients in the Pre‐Elimination Context of Nepal

Ghimire P. et al, (2026), Tropical Medicine & International Health

G6PD deficiency in Indonesia: a systematic review and update of prevalence and variant maps in the context of malaria elimination

Sadhewa A. et al, (2026), The Lancet Regional Health - Western Pacific, 69, 101840 - 101840

Chronic Malaria Is Associated With Trauma-related Splenic Rupture Requiring Splenectomy

Shanti PAI. et al, (2026), The Journal of Infectious Diseases, 233, e740 - e744

Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation

Hafidzah M. et al, (2026), The Journal of Infectious Diseases

Temporal trends in Plasmodium vivax diversity in eastern Cambodia evidence declining transmission.

Eam R. et al, (2026)

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial

Degaga TS. et al, (2026), The Lancet Infectious Diseases

Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders

Dysoley L. et al, (2026), Malaria Journal, 25

Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?

Unger HW. et al, (2026), The Lancet Global Health, 14, e157 - e163

Rapid detection of G6PD deficiency SNPs using a novel amplicon-based minion sequencing assay

Tacoli C. et al, (2025), Scientific Reports, 16

Enhancing unique identification of patients with malaria using biometric fingerprinting in Papua, Indonesia

Fransisca L. et al, (2025), Malaria Journal, 25

Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study

Shifraw T. et al, (2025), Malaria Journal, 25

Systematic review and individual patient data meta-analysis on glucose- 6 – phosphate dehydrogenase activities measured by a semi-quantitative handheld biosensor

Ley B. et al, (2025), Malaria Journal, 24

Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis

Fadilah I. et al, (2025)

Load More

1
2
3
4
5
6
7
...
»